Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Nashan

Showing results (41-50 of 122) with videos related to

Pageof 13
Sort By:
Transplantation Proceedings|October 1, 1990
Transplantation aspiration cytology in the diagnosis of steroid resistant rejection in liver allograft patientsB Nashan, H J Schlitt, B Ringe, et al.
Transplantation Proceedings|February 1, 1995
Evidence for transformation of lipocytes to myofibroblast-like cells as source of transplant fibrosis in chronic human allograft rejectionK Hoshino, G Demirci, H J Schlitt, et al.
Transplantation Proceedings|February 1, 1994
Steroid-resistant rejection after renal transplantationP F Hoyer, G Offner, J Brodehl, et al.
Clinical Pharmacology and Therapeutics|August 8, 1998
Disposition and immunodynamics of basiliximab in liver allograft recipientsJ Kovarik, T Breidenbach, C Gerbeau, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 10, 2013
Cognitive performance in pediatric liver transplant recipientsT Kaller, N Langguth, F Petermann, et al.
Transplantation|September 10, 1999
Attitudes of patients before and after transplantation towards various allograftsH J Schlitt, R Brunkhorst, H H Schmidt, et al.
HLA|November 8, 2017
The killer cell lectin-like receptor B1 (KLRB1) 503T>C polymorphism (rs1135816) and acute rejection after liver transplantationH Thude, S Rother, M Sterneck, et al.
Lancet (London, England)|July 4, 1998
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study GroupB Nashan, R Moore, P Amlot, et al.
Transplantation Proceedings|August 1, 1989
Patterns of immune activation during the first four weeks in liver transplant patientsB Nashan, H J Schlitt, C W Wittekind, et al.
Arzneimittel-Forschung|January 1, 1990
Single dose pharmacokinetics of ciclosporin and its main metabolites after oral ciclosporin as oily solution or capsuleJ S Bleck, B Nashan, U Christians, et al.
Pageof 13

Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
Transplantation Proceedings|October 1, 1990
Transplantation aspiration cytology in the diagnosis of steroid resistant rejection in liver allograft patientsB Nashan, H J Schlitt, B Ringe, et al.
Transplantation Proceedings|February 1, 1995
Evidence for transformation of lipocytes to myofibroblast-like cells as source of transplant fibrosis in chronic human allograft rejectionK Hoshino, G Demirci, H J Schlitt, et al.
Transplantation Proceedings|February 1, 1994
Steroid-resistant rejection after renal transplantationP F Hoyer, G Offner, J Brodehl, et al.
Clinical Pharmacology and Therapeutics|August 8, 1998
Disposition and immunodynamics of basiliximab in liver allograft recipientsJ Kovarik, T Breidenbach, C Gerbeau, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 10, 2013
Cognitive performance in pediatric liver transplant recipientsT Kaller, N Langguth, F Petermann, et al.
Transplantation|September 10, 1999
Attitudes of patients before and after transplantation towards various allograftsH J Schlitt, R Brunkhorst, H H Schmidt, et al.
HLA|November 8, 2017
The killer cell lectin-like receptor B1 (KLRB1) 503T>C polymorphism (rs1135816) and acute rejection after liver transplantationH Thude, S Rother, M Sterneck, et al.
Lancet (London, England)|July 4, 1998
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study GroupB Nashan, R Moore, P Amlot, et al.
Transplantation Proceedings|August 1, 1989
Patterns of immune activation during the first four weeks in liver transplant patientsB Nashan, H J Schlitt, C W Wittekind, et al.
Arzneimittel-Forschung|January 1, 1990
Single dose pharmacokinetics of ciclosporin and its main metabolites after oral ciclosporin as oily solution or capsuleJ S Bleck, B Nashan, U Christians, et al.
Pageof 13